Resources
21 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 7/31/2023 (updated 3/26/2024)
At the end of July 2023, the U.S. Food and Drug Administration approved a second over-the-counter naloxone nasal spray product, RiVive. The agency who received the approval to manufacture the product, Harm Reduction Therapeutics, does not yet have a timeline of availability and decision on pricing.
Posted 9/4/2023 (updated 3/26/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) has created a toolkit for National Recovery Month 2023 to support people in recovery from mental and substance use disorders. The toolkit includes social media content material, resources for recovery, and recovery promotional materials.
Posted 9/5/2023 (updated 3/26/2024)
Visit the Substance Abuse and Mental Health Services Administration (SAMHSA) to learn more about National Recovery Month, held every September. National Recovery Month is dedicated to promoting and supporting new evidence-based treatment and recovery practices. Find events, read President Biden's proclamation on National Recovery month, and discover many resources which can be utilized in your organization and community.
Posted 4/26/2022 (updated 3/27/2024)
Overview of the jail-based Medication Assisted Treatment program within the Adult Detention Center in Fairfax County, Virginia.
Posted 9/25/2023 (updated 3/27/2024)
The Bureau of Justice Assistance’s (BJA) Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) has provided events and resources throughout September 2023 for National Recovery Month.
Posted 4/4/2023 (updated 3/27/2024)
The U.S. Food and Drug Administration (FDA) announced that the makers of Narcan, an opioid overdose treatment, have the agency’s approval to make the drug widely available over the counter (OTC). Narcan is the brand name of the drug naloxone, a fast-acting overdose reversal. Until now, availability varied by state – typically restricted to licensed health care providers, approved opioid overdose programs, and first responders. This is an important consideration for rural counties given that research shows that these areas are nearly three times more likely than metropolitan counties to be a low-dispensing county for naloxone.
Posted 4/11/2023 (updated 3/27/2024)
The first phase of the campaign created by the White House Office of National Drug Control Policy (ONDCP) and Ad Council was launched to education young people on the dangers of fentanyl and the life-saving effects of Naloxone, a medicine that reverses opioid-related overdoses. This campaign expands on the Ad Council's The Real Deal on Fentanyl platform.
Posted 5/26/2023 (updated 3/27/2024)
Start your journey to better mental health today and find your support system on FindSupport.gov. Let’s honor the memories of those we have lost and prevent others from managing their mental health challenges alone. If you or someone you know is in a mental health crisis, Text or call 988 or chat 988lifeline.org for free, confidential support 24/7
Posted 11/17/2023 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) has published the new resource "Counseling Approaches To Promote Recovery From Problematic Substance Use and Related Issues". This Treatment Improvement Protocol (TIP) provides guidance to counselors, administrators, and supervisors about recovery-oriented services, supports, and care, allowing them to better serve individuals in or seeking recovery from problematic substance use.
Posted 1/19/2024 (updated 3/28/2024)
The FDA announced that the manufacturer of NARCAN 4 mg Nasal Spray products, Emergent BioSolutions, has extended the shelf-life of their product from 3 years to 4 years. This new extension of shelf-life was requested by the FDA to help prevent overdoses and reduce overdose-related deaths.